Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTJFA35)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

5 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AMG-714	DM1T3KQ	Coeliac disease	DA95	Phase 2	[1]
BNZ-1	DM8JQZC	Cutaneous T-cell lymphoma	2B01	Phase 2	[2]
SAR445877	DM91KZL	Aggressive cancer	2A00-2F9Z	Phase 2	[3]
N-803	DM4ZN8M	Human immunodeficiency virus infection	1C62	Phase 1	[4]
PF-07209960	DM1W90B	Aggressive cancer	2A00-2F9Z	Phase 1	[5]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
2	Clinical pipeline report, company report or official report of Bioniz Therapeutics.
3	Clinical pipeline report, company report or official report of Sanofi
4	The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques. PLoS Pathog. 2020 Mar 12;16(3):e1008339.
5	ClinicalTrials.gov (NCT04628780) A PHASE 1 DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTI-TUMOR ACTIVITY OF PF-07209960 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS. U.S.National Institutes of Health.